Gene · 135152
Papers1,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypericin and hyperforin from St. John's Wort are potent intestinal UGT inhibitors with distinct binding modes: mechanistic and quantitative prediction of clinical drug-drug interaction risk. | Front Pharmacol | 2026 | 42787300 | PubTator, text mining | PubMed |
| Coumarins at the Crossroads of Drug Development: Enzyme Modulation for Clinical Advances. | Indian J Clin Biochem | 2026 | 42712839 | PubTator, text mining | PubMed |
| Multilayered clearance concept: a membrane-resolved flux framework for drug metabolism. | Biochem Pharmacol | 2026 | 42702242 | PubTator, text mining | PubMed |
| The Dual Role of Human UDP-Glucuronosyltransferase-Mediated Metabolism in Tumor Drug Resistance: Mechanisms and Prospects. | Int J Mol Sci | 2026 | 42589609 | PubTator, text mining | PubMed |
| Testosterone and epitestosterone differentially regulate UDP-glucuronosyltransferases (UGT) activity. | J Steroid Biochem Mol Biol | 2026 | 42303060 | PubTator, text mining | PubMed |
| Cellular pharmacology of fludarabine: molecular determinants of transport and metabolism. | Front Pharmacol | 2026 | 42239518 | PubTator, text mining | PubMed |
| Extracellular vesicles as xenobiotic-metabolizing enzyme carriers: a new paradigm for brain drug metabolism. | Drug Metab Rev | 2026 | 42060154 | PubTator, text mining | PubMed |
| An Overview of Cannabinoid Interactions With Common Pediatric Antineoplastic Agents. | Pediatr Blood Cancer | 2026 | 42057496 | PubTator, text mining | PubMed |
| Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen. | J Pers Med | 2026 | 42042555 | PubTator, text mining | PubMed |
| Systematic transcriptomic analysis of UDP-glucuronosyltransferases reveals UGT2B11 as a diagnostic and metabolic marker in hepatocellular carcinoma. | BMC Cancer | 2026 | 42015107 | PubTator, text mining | PubMed |
| Research Progress on Anticancer Mechanism of Ginsenoside Regulating Tumor Microenvironment. | Curr Issues Mol Biol | 2026 | 41899480 | PubTator, text mining | PubMed |
| Modulation of Macrophage Inflammatory Responses by UDP-Glucuronosyltransferase-Mediated PGE2 Glucuronidation. | J Pers Med | 2026 | 41893027 | PubTator, text mining | PubMed |
| The involvement of miRNAs in CYP450 enzymes and UDP-glucuronosyltransferases regulation in the human liver. | Sci Rep | 2026 | 41857360 | PubTator, text mining | PubMed |
| Prevalence of non-cytochrome P450-mediated metabolism in food and drug administration-approved drugs: 2005-2024. | Drug Metab Dispos | 2026 | 41831426 | PubTator, text mining | PubMed |
| Novel insights into UDP-glucuronosyltransferase 1A1 dysfunction and Gilbert's syndrome on estrogen metabolism and breast cancer. | Crit Rev Oncol Hematol | 2026 | 41806906 | PubTator, text mining | PubMed |
| Sesamin exhibits potential food-drug interactions through the inhibition of cytochrome P450s and human UDP-glucuronosyltransferases in vitro. | RSC Adv | 2026 | 41799916 | PubTator, text mining | PubMed |
| Pharmacological inhibition of frizzled 4 delays cell cycle progression and limits oral squamous cell carcinoma growth. | Front Cell Dev Biol | 2026 | 41783595 | PubTator, text mining | PubMed |
| Managing High-Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service. | Clin Transl Sci | 2026 | 41772767 | PubTator, text mining | PubMed |
| PLCG1 promotes sevoflurane-induced neuronal ferroptosis by enhancing K63-linked ubiquitination and proteasomal degradation of LAMP2A. | Exp Brain Res | 2026 | 41758220 | PubTator, text mining | PubMed |
| Inhibition of Four Anaplastic Lymphoma Kinase Inhibitors on the Activity of Human UDP-Glucuronosyltransferases and Prediction of Drug-Drug Interactions. | Chem Res Toxicol | 2026 | 41755788 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/135152/papers